Extend Biosciences
Extend Biosciences Inc.: Innovating efficient drug delivery platforms for peptides and proteins.
Founded
2010Extend Biosciences Inc.: Innovating efficient drug delivery platforms for peptides and proteins.
Founded in Cambridge, United States, Extend Biosciences Inc. is a clinical-stage biotechnology company focused on developing innovative drug delivery platforms. Their core mission is to enhance the pharmacokinetic properties of peptides and proteins, transforming them into long-acting therapeutics. By addressing the challenges associated with the rapid removal of peptides from circulation, Extend Biosciences aims to improve the efficiency and sustainability of peptide and protein-based treatments.
Notable figures affiliated with Extend Biosciences include leading scientists and industry experts in biotechnology. The company has attracted significant interest from investors due to its groundbreaking technology and potential to revolutionize drug delivery systems. Key achievements include the successful development and clinical testing of their novel platform, which has shown promising results in extending the half-life of therapeutic peptides. Overall, Extend Biosciences is making a substantial impact on the biotechnology field by enabling more effective and sustained delivery of vital medications.
Companies similar to Extend Biosciences include InSitu Biologics, Longevity Biotech, Enable Therapeutics and Endevica Bio.
Extend Biosciences was founded in 2010.
Extend Biosciences' headquarters is located in Cambridge, MA, US.
Extend Biosciences' most recent funding round was for $908k (USD) in November 2014.
As of Nov 10, 2014, Extend Biosciences has disclosed funding of $1.1M (USD). Undisclosed round amounts are excluded.
Extend Biosciences has 4 employees as of Feb 4, 2024.
endevicabio.com
